CSI Market
Sign In | Register

Tandem Diabetes Care Inc (TNDM) Quarterly Income Statement

Quarterly · GAAP · USD millions
Access TNDM Annual Income Statement →
Reviewing income statement figures over time helps illustrate how Tandem Diabetes Care Inc generates earnings and manages operating expenses.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
Q1 2026 		(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Revenues
Revenue From Contract With Customer Excluding Assessed Tax247.22
Total Revenue246.79
Costs & Expenses
Cost of Goods and Services Sold110.00
Gross Profit136.79
Selling, Administration, Marketing108.19
Research and Development Expense (Excluding Acquired in Process Cost)46.04
Other Operating Expense / -Income0.00
Litigation Settlement, Expense0.00
Total operating costs including COS264.22
Operating income / -loss-17.43
Interest Income0.00
Net Interest Expense / -Income0.00
Loss (Income) from Equity Method Investments-3.87
Other loss / -income4.89
Total costs & expenses266.67
Income & Taxes
Income / -loss before income taxes-19.88
Income taxes expenses / -benefit0.52
Income after income taxes-20.39
Income / -loss from continuing operations-20.39
Net income / -loss-20.39
Income / -loss to shareholder-20.39
EBIT-19.88
EBITD-15.37
EBITDA-14.80
Earnings Per Share
Basic EPS (excl. extra items)-0.30
Basic Net EPS-0.30
Basic shares outstanding (Mill. of Units)68.40
Diluted Net EPS-0.30
Diluted average shares (Mill. of Units)68.40
4 historic quarters locked

Sign in to unlock the full Tandem Diabetes Care Inc income statement history.

Sign In Create Free Account

About Tandem Diabetes Care Inc Quarterly Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-Q filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-Q filings
  • Filed with the SEC: August 6, 2026
  • Original filing: tndm-20260630.htm

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.